PRESS RELEASES

ATMI, Inc. - ATMI Introduces Ready-to-Use, Sterile Pyrofree(R) Vials

Print Print page   Email Email page   PDF Download PDF    Add to Briefcase
« Previous Release | Next Release »



ATMI Introduces Ready-to-Use, Sterile Pyrofree(R) Vials

DANBURY, Conn., Sept. 18, 2013 (GLOBE NEWSWIRE) -- ATMI, Inc. (Nasdaq:ATMI), a global technology company and leader in single-use bioprocess solutions, has introduced a line of pyrogen-free vials in collaboration with Disposable Lab (D-Lab), a Bordeaux, France-based contract-manufacturing company. Designed to meet biopharmaceutical filling and final packaging needs, the patent-pending Pyrofree® vials are the only cost effective, ready-to-use vials guaranteed to be both pyrogen-free and sterile upon delivery.

"We have come together with D-Lab to offer this comprehensive solution in support of our customers' end goal of advancing patient health and safety," said Senior Vice President and General Manager of ATMI LifeSciences, Mario Philips. "Pyrofree vials can be incorporated into ATMI's existing ultra-clean sterile packaging and fill/finish technologies, or used independently."

Pyrogens are a substance that induce rapid onset of fever with the potential to cause sepsis or progressive septic shock if they enter a patient's bloodstream. This makes it critical to ensure that pyrogens are not present in biopharmaceutical products. While difficult, the most common techniques to remove pyrogens are either inactivation or destruction of the molecule through depyrogenation.

ATMI subjects all Pyrofree vials to a thorough depyrogenation process that includes washing (with water for injection) and heating the vials to high temperatures in a polyether ether ketone (PEEK) bag to achieve a three-log reduction. Process specifications can be further modified based on customer requests.

"Pyrofree brings several clear benefits including the most cost-effective solution on the market, scalability from small to commercial-scale batches, and availability in both molded and tubular formats," noted Jean-Pascal Zambaux, inventor of Pyrofree and majority owner of D-Lab. "The vials may also be used for commercial safety stocks of injectables, and feature sizes up to 1 liter."

Pyrofree vials are made to withstand the high temperatures during depyrogenation and sterilization. After these steps, the vials are double-vacuum-packed in a PEEK bag for tamper-evidence, as well as to maintain sterility and guarantee no external contact. A third PE/PA film layer is added to the packaging under vacuum in a Class C cleanroom to protect the vials from any breakage during transportation and eliminate the need for a support tray.

Pyrofree vials are currently available for sale. You can learn more about the Pyrofree vials and technology by visiting: http://www.atmi.com/lifesciences/products/pyrofree/

About ATMI

ATMI Inc. provides specialty semiconductor materials, and safe, high-purity materials handling and delivery technologies designed to increase process efficiencies for the global semiconductor, flat-panel and life sciences industries. For more information, please visit http://www.atmi.com.

About ATMI LifeSciences

ATMI LifeSciences is an acknowledged technology leader in the field of single-use bioprocess systems and consumables for the pharmaceutical and biopharmaceutical industries. Its innovative, market-leading portfolio of custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors is driving bioprocess efficiency and delivering value for biopharmaceutical companies around the world. For more information, please visit www.atmi-lifesciences.com.

About Disposable-Lab

Disposable-Lab SAS is a pharmaceutical company which develops innovative technologies based on a disposable isolator and disposable process equipment. Disposable-Lab SAS is offering the life sciences industry a new way to manufacture sterile drugs, enabling dramatic reductions in time and costs. Disposable-Lab is located in Bordeaux Montesquieu (France) where it also serves as a contract manufacturing organization (CMO). It is the first pharmaceutical facility featuring only disposable equipment, including a single-use isolator for sterile manufacturing of liquid and freeze-dried products, that is scalable up to 200L.

ATMI and the ATMI logo are trademarks or registered trademark of Advanced Technology Materials, Inc. in the U.S., other countries, or both. Pyrofree is a registered trademark of Disposable-Lab SAS.

Forward-Looking Statements

Statements contained herein that relate to ATMI's future performance, including, without limitation, statements with respect to ATMI's anticipated results of operations or level of business for 2013 or any other future period, are forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations only and are subject to certain risks, uncertainties and assumptions, including, but not limited to, changes in semiconductor and life sciences industry growth (including, without limitation, wafer starts) or ATMI's markets; competition, problems or delays developing, commercializing and delivering new products; customer-driven pricing pressure; potential loss of key customers; problems or delays in integrating acquired operations and businesses; uncertainty in the credit and financial markets; ability to protect ATMI's proprietary technology; and other factors described in ATMI's Form 10-K for the year ended December 31, 2012 and other subsequent filings with the Securities and Exchange Commission. Such risks and uncertainties may cause actual results to differ materially from those expressed in our forward-looking statements. ATMI undertakes no obligation to update any forward-looking statements.

CONTACT: ATMI Contact:

         Troy Dewar

         Director of Investor Relations and Corporate Communications

         203.207.9349

         tdewar@atmi.com



         Media Contact:

         Beth Willers

         Impress Labs

         415.846.9891

         beth@impresslabs.com

company logo

Source: ATMI, Inc.

News Provided by Acquire Media

Close window | Back to top

Stock Information
NASDAQ:ATMI
$33.99   + 0.02
Apr 17, 2014
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.

Transfer Agent
Continental Stock Transfer & Trust Company
17 Battery Place – 8th Floor
New York, NY 10004
Attn. Transfer Department
1-800-509-5586 or
212-509-4000
cstmail@continentalstock.com